Lanxi Hospital of Traditional Chinese Medicine
4
0
2
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 85/100
25.0%
1 terminated/withdrawn out of 4 trials
0.0%
-86.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (4)
Multi-cancer Joint Screening and Early Diagnosis and Treatment Project Based on the Combination of Chinese Traditional and Western Medicine in Lanxi City
Role: lead
A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills
Role: collaborator
Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases
Role: collaborator
Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study
Role: collaborator
All 4 trials loaded